Biblio Discovery — Demo Discovery Service

33 results for "Annette Paschen"

Showing 1–20 · 2.53 seconds · RSS

  1. Journal Article

    Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance

    Beatrice Thier; Annette Paschen

    Cell Stress, Vol. 5 No. 2 · 2021 · English · DOAJ Scopus

    In recent years, therapy with immune modulating antibodies, termed immune checkpoint blockade (ICB), has revolutionized the treatment of advanced metastatic melanoma, yielding long-lasting clinical responses in a subgroup of patients. But despite this remarkable progress, resistance to therapy…

  2. Journal Article

    Orthanq: transparent and uncertainty-aware haplotype quantification with application in HLA-typing

    Hamdiye Uzuner; Annette Paschen; Dirk Schadendorf et al.

    BMC Bioinformatics, Vol. 25 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background Identification of human leukocyte antigen (HLA) types from DNA-sequenced human samples is important in organ transplantation and cancer immunotherapy and remains a challenging task considering sequence homology and extreme polymorphism of HLA genes. Results We present Orthanq, a…

  3. Journal Article

    Cytotoxic CD4+ T cells in chronic viral infections and cancer

    Anna Malyshkina; Alicia Brüggemann; Annette Paschen et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    CD4+ T cells play an important role in immune responses against pathogens and cancer cells. Although their main task is to provide help to other effector immune cells, a growing number of infections and cancer entities have been described in which CD4+ T cells exhibit direct effector functions…

  4. Journal Article

    Targeting the recurrent Rac1P29S neoepitope in melanoma with heterologous high-affinity T cell receptors

    Lena Immisch; George Papafotiou; Nerea Gallarín Delgado et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    Recurrent neoepitopes are cancer-specific antigens common among groups of patients and therefore ideal targets for adoptive T cell therapy. The neoepitope FSGEYIPTV carries the Rac1P29S amino acid change caused by a c.85C>T missense mutation, which is the third most common hotspot mutation in…

  5. Journal Article Full text

    Screening of Human Tumor Antigens for CD4 + T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries

    Wolfram Osen; Sabine Soltek; Mingxia Song et al.

    PLoS ONE, Vol. 5 No. 11 · 2010 · English · PLOS Scopus

    Background: As tumor antigen-specific CD4+ T cells can mediate strong therapeutic anti-tumor responses in melanoma patients we set out to establish a comprehensive screening strategy for the identification of tumor-specific CD4+ T cell epitopes suitable for detection, isolation and expansion of…

    Also available at: DOAJ

  6. Journal Article

    Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma

    Cathrin Ritter; Kaiji Fan; Annette Paschen et al.

    Scientific Reports, Vol. 7 No. 1 · 2017 · English · DOAJ Scopus

    Abstract Merkel cell carcinoma (MCC) is a rare and aggressive, yet highly immunogenic skin cancer. The latter is due to its viral or UV-associated carcinogenesis. For tumor progression MCC has to escape the host’s immuno-surveillance, e.g. by loss of HLA class-I expression. Indeed, a reduced HLA…

  7. Journal Article

    Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors

    Sheila López-Cobo; Natalia Pieper; Carmen Campos-Silva et al.

    OncoImmunology, Vol. 7 No. 2 · 2018 · English · DOAJ Scopus

    Therapy of metastatic melanoma advanced recently with the clinical implementation of signalling pathway inhibitors, such as vemurafenib, specifically targeting mutant BRAFV600E. In general, patients experience remarkable clinical responses under BRAF inhibitor (BRAFi) treatment but eventually…

  8. Journal Article

    Activated Tissue-Resident Mesenchymal Stromal Cells Regulate Natural Killer Cell Immune and Tissue-Regenerative Function

    Robert Michael Petri; Alexander Hackel; Katrin Hahnel et al.

    Stem Cell Reports, Vol. 9 No. 3 · 2017 · English · DOAJ Scopus

    The interaction of mesenchymal stromal cells (MSCs) with natural killer (NK) cells is traditionally thought of as a static inhibitory model, whereby resting MSCs inhibit NK cell effector function. Here, we use a dynamic in vitro system of poly(I:C) stimulation to model the interaction of NK cells…

  9. Journal Article

    Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptors

    Korbinian N. Kropp; Martina Fatho; Enes Huduti et al.

    Frontiers in Immunology, Vol. 14 · 2023 · English · DOAJ Scopus

    IntorductionChondroitin sulfate proteoglycan 4 (CSPG4), also known as high molecular weight-melanoma associated antigen, is expressed in melanoma but also other tumor entities and constitutes an attractive target for immunotherapeutic approaches. While recent preclinical reports focused on…

  10. Journal Article

    SILAC-based quantification reveals modulation of the immunopeptidome in BRAF and MEK inhibitor sensitive and resistant melanoma cells

    Melissa Bernhardt; Anne Rech; Marion Berthold et al.

    Frontiers in Immunology, Vol. 15 · 2025 · English · DOAJ Scopus

    BackgroundThe immunopeptidome is constantly monitored by T cells to detect foreign or aberrant HLA peptides. It is highly dynamic and reflects the current cellular state, enabling the immune system to recognize abnormal cellular conditions, such as those present in cancer cells. To precisely…

  11. Journal Article Full text

    Expression of Potential Targets for Cell-Based Therapies on Melanoma Cells

    Sophia B. Strobel; Devayani Machiraju; Ingrid Hülsmeyer et al.

    Life, Vol. 11 No. 4 · 2021 · English · DOAJ Scopus

    Tumor antigen-specific redirection of cytotoxic T cells (CTLs) or natural killer (NK) cells including chimeric antigen receptor (CAR-) and T cell receptor (TCR-) cell therapy is currently being evaluated in different tumor entities including melanoma. Expression of melanoma-specific antigen…

  12. Journal Article

    Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection

    Anna Malyshkina; Elisabeth Littwitz-Salomon; Kathrin Sutter et al.

    Scientific Reports, Vol. 7 No. 1 · 2017 · English · DOAJ Scopus

    Abstract CD4+ helper T cells and cytotoxic CD8+ T cells are key players for adaptive immune responses against acute infections with retroviruses. Similar to textbook knowledge the most important function of CD4+ T cells during an acute retrovirus infection seems to be their helper function for…

  13. Journal Article

    Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma

    Sheila López-Cobo; Carmen Campos-Silva; Amanda Moyano et al.

    Journal of Nanobiotechnology, Vol. 16 No. 1 · 2018 · English · DOAJ Scopus

    Abstract Background Tumour-derived exosomes can be released to serum and provide information on the features of the malignancy, however, in order to perform systematic studies in biological samples, faster diagnostic techniques are needed, especially for detection of low abundance proteins. Most…

  14. Journal Article

    Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response

    Kim Denise Fischer; Shashank Tiwari; Beatrice Thier et al.

    Frontiers in Molecular Biosciences, Vol. 11 · 2024 · English · DOAJ Scopus

    Melanoma is a highly malignant tumor, that stands as the most lethal form of skin cancer and is characterized by notable phenotypic plasticity and intratumoral heterogeneity. Melanoma plasticity is involved in tumor growth, metastasis and therapy resistance. Long non-coding RNAs (lncRNAs) could…

  15. Journal Article

    MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated

    Silvia López-Borrego; Carmen Campos-Silva; Amaia Sandúa et al.

    Frontiers in Cell and Developmental Biology, Vol. 10 · 2023 · English · DOAJ Scopus

    Metastatic melanoma presents, in many cases, oncogenic mutations in BRAF, a MAPK involved in proliferation of tumour cells. BRAF inhibitors, used as therapy in patients with these mutations, often lead to tumour resistance and, thus, the use of MEK inhibitors was introduced in clinics. BRAFi/MEKi…

  16. Journal Article

    Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids

    Myriam Oliveira-Rodríguez; Sheila López-Cobo; Hugh T. Reyburn et al.

    Journal of Extracellular Vesicles, Vol. 5 No. 0 · 2016 · English · DOAJ Scopus

    Exosomes are cell-secreted nanovesicles (40–200 nm) that represent a rich source of novel biomarkers in the diagnosis and prognosis of certain diseases. Despite the increasingly recognized relevance of these vesicles as biomarkers, their detection has been limited due in part to current technical…

  17. Journal Article

    Arenavirus Induced CCL5 Expression Causes NK Cell-Mediated Melanoma Regression

    Hilal Bhat; Gregor Zaun; Thamer A. Hamdan et al.

    Frontiers in Immunology, Vol. 11 · 2020 · English · DOAJ Scopus

    Immune activation within the tumor microenvironment is one promising approach to induce tumor regression. Certain viruses including oncolytic viruses such as the herpes simplex virus (HSV) and non-oncolytic viruses such as the lymphocytic choriomeningitis virus (LCMV) are potent tools to induce…

  18. Journal Article

    Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotype

    Lea Jessica Albrecht; Anna Höwner; Klaus Griewank et al.

    Clinical and Translational Medicine, Vol. 12 No. 11 · 2022 · English · DOAJ Scopus

    Abstract Background Plasma‐derived tumour‐specific cell‐free nucleic acids are increasingly utilized as a minimally invasive, real‐time biomarker approach in many solid tumours. Circulating tumour DNA of melanoma‐specific mutations is currently the best studied liquid biopsy biomarker for melanoma…